Accelerate Diagnostics closes asset sale; Chapter 11 liquidation plan confirmed, equity canceled

Accelerate Diagnostics, Inc

On August 8, 2025, closed sale of certain assets to Indaba Starling (affiliate of Indaba Capital) under amended asset purchase agreement.
On August 13, 2025, Bankruptcy Court confirmed Second Amended Combined Disclosure Statement and Chapter 11 Plan of Liquidation.
Plan effective date expected on or about August 18, 2025; all common stock and warrants canceled, holders receive no distribution.
As of confirmation, company had approximately 25,477,516 shares outstanding with no shares reserved for future issuance.

item 1.01item 1.03item 2.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.